These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17183147)

  • 21. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.
    Lai CQ; Arnett DK; Corella D; Straka RJ; Tsai MY; Peacock JM; Adiconis X; Parnell LD; Hixson JE; Province MA; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1417-25. PubMed ID: 17431185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic variants of apolipoprotein A5 T-1131C and apolipoprotein E common polymorphisms and their relationship to features of metabolic syndrome in adult dyslipidemic patients.
    Novotny D; Vaverkova H; Karasek D; Malina P
    Clin Biochem; 2014 Aug; 47(12):1015-21. PubMed ID: 24709297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
    Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
    Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case-control study of apoA5 -1131T-->C polymorphism that examines the role of triglyceride levels in diabetic nephropathy.
    Baum L; Ng MC; So WY; Poon E; Wang Y; Lam VK; Tomlinson B; Chan JC
    J Diabetes Complications; 2007; 21(3):158-63. PubMed ID: 17493548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia.
    van der Vleuten GM; Isaacs A; Zeng WW; ter Avest E; Talmud PJ; Dallinga-Thie GM; van Duijn CM; Stalenhoef AF; de Graaf J
    Biochim Biophys Acta; 2007 Jan; 1772(1):81-8. PubMed ID: 17157483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II.
    Talmud PJ; Cooper JA; Hattori H; Miller IP; Miller GJ; Humphries SE
    Diabetologia; 2006 Oct; 49(10):2337-40. PubMed ID: 16917759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein A5 gene polymorphism -1131T-->C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese.
    Yan SK; Cheng XQ; Song YH; Xiao XH; Bi N; Chen BS
    Clin Chem Lab Med; 2005; 43(6):607-12. PubMed ID: 16006256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study.
    Tsolaki AC; Gatzima O; Daniilidou M; Lazarou E; Bamidis PD; Verykouki E; Iakovidou-Kritsi Z; Tsolaki M
    Neurodegener Dis; 2018; 18(4):216-224. PubMed ID: 30205398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOA5-1131T>C polymorphism is associated with triglyceride levels in Chinese men.
    Baum L; Tomlinson B; Thomas GN
    Clin Genet; 2003 May; 63(5):377-9. PubMed ID: 12752569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of APOA5 -1131T>C and S19W gene polymorphisms with both mild hypertriglyceridemia and hyperchylomicronemia in type 2 diabetic patients.
    Charriere S; Bernard S; Aqallal M; Merlin M; Billon S; Perrot L; Le Coquil E; Sassolas A; Moulin P; Marcais C
    Clin Chim Acta; 2008 Aug; 394(1-2):99-103. PubMed ID: 18468520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
    Hiramatsu M; Oguri M; Kato K; Horibe H; Fujimaki T; Watanabe S; Satoh K; Aoyagi Y; Tanaka M; Shin DJ; Lee JH; Jang Y; Yamada Y
    Int J Mol Med; 2012 Jul; 30(1):185-92. PubMed ID: 22576629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of plasma lipids during weight reduction in females depends on APOA5 variants.
    Suchanek P; Lorenzova A; Poledne R; Hubacek JA
    Ann Nutr Metab; 2008; 53(2):104-8. PubMed ID: 18946207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients.
    Horvatovich K; Bokor S; Baráth A; Maász A; Kisfali P; Járomi L; Polgár N; Tóth D; Répásy J; Endreffy E; Molnár D; Melegh B
    Int J Pediatr Obes; 2011 Jun; 6(2-2):e318-25. PubMed ID: 20883102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Relation between Metabolic Syndrome Risk Factors and Genetic Variations of Apolipoprotein V in Relation with Serum Triglyceride and HDL-C Level.
    Fallah MS; Sedaghatikhayat B; Guity K; Akbari F; Azizi F; Daneshpour MS
    Arch Iran Med; 2016 Jan; 19(1):46-50. PubMed ID: 26702748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of apolipoprotein A5 gene polymorphisms in Hubei Han people].
    Ding Y; Zhu MA; Zhou YL; Wang ZX; Yang GL
    Yi Chuan; 2007 May; 29(5):554-8. PubMed ID: 17548323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of association of neprilysin gene polymorphisms with Alzheimer's disease in a southern Chinese community.
    Fu Y; Li AF; Shi JJ; Tang MN; Guo YB; Zhao ZH
    Int Psychogeriatr; 2009 Apr; 21(2):354-8. PubMed ID: 19250583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of APOA1 and APOA5 polymorphisms and haplotypes with lipid parameters in a Brazilian elderly cohort.
    Furuya TK; Chen ES; Ota VK; Mazzotti DR; Ramos LR; Cendoroglo MS; Araujo LQ; Burbano RR; Smith MA
    Genet Mol Res; 2013 Feb; 12(3):3495-9. PubMed ID: 23479152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke.
    Havasi V; Szolnoki Z; Talián G; Bene J; Komlósi K; Maász A; Somogyvári F; Kondacs A; Szabó M; Fodor L; Bodor A; Melegh B
    J Mol Neurosci; 2006; 29(2):177-83. PubMed ID: 16954607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia.
    Wang J; Ban MR; Kennedy BA; Anand S; Yusuf S; Huff MW; Pollex RL; Hegele RA
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):730-7. PubMed ID: 18779834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
    Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
    Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.